Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larisa H Cavallari

Showing results (1-10 of 219) with videos related to

Pageof 22
Sort By:
Expert Review of Cardiovascular Therapy|July 13, 2017
Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary interventionLarisa H Cavallari
Future Cardiology|October 7, 2009
Pharmacogenomics in heart failure: individualizing therapy based on genotypeLarisa H Cavallari
Future Cardiology|October 7, 2009
beta-adrenergic receptor pharmacogeneticsLarisa H Cavallari
Future Cardiology|October 3, 2017
Time to revisit warfarin pharmacogeneticsLarisa H Cavallari
Journal of Pharmacy Practice|August 22, 2012
Tailoring drug therapy based on genotypeLarisa H Cavallari
JACC. Cardiovascular Interventions|September 1, 2024
Genotype-Guided De-Escalation of DAPT: Switching to Real-World PracticeLarisa H Cavallari, Francesco Franchi
Pharmacotherapy|July 27, 2010
Clopidogrel and proton pump inhibitors: between a rock and a hard placeKathryn Momary, Larisa H Cavallari
JACC. Cardiovascular Interventions|March 10, 2023
Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves EastLarisa H Cavallari, Francesco Franchi
Future Cardiology|May 30, 2015
Pharmacogenomics in cardiology--genetics and drug response: 10 years of progressLarisa H Cavallari, Kristin Weitzel
Trends in Cardiovascular Medicine|October 6, 2014
Warfarin pharmacogeneticsJulie A Johnson, Larisa H Cavallari
Pageof 22

Showing results (1-10 of 219) with videos related to

Sort By:
Pageof 22
Expert Review of Cardiovascular Therapy|July 13, 2017
Personalizing antiplatelet prescribing using genetics for patients undergoing percutaneous coronary interventionLarisa H Cavallari
Future Cardiology|October 7, 2009
Pharmacogenomics in heart failure: individualizing therapy based on genotypeLarisa H Cavallari
Future Cardiology|October 7, 2009
beta-adrenergic receptor pharmacogeneticsLarisa H Cavallari
Future Cardiology|October 3, 2017
Time to revisit warfarin pharmacogeneticsLarisa H Cavallari
Journal of Pharmacy Practice|August 22, 2012
Tailoring drug therapy based on genotypeLarisa H Cavallari
JACC. Cardiovascular Interventions|September 1, 2024
Genotype-Guided De-Escalation of DAPT: Switching to Real-World PracticeLarisa H Cavallari, Francesco Franchi
Pharmacotherapy|July 27, 2010
Clopidogrel and proton pump inhibitors: between a rock and a hard placeKathryn Momary, Larisa H Cavallari
JACC. Cardiovascular Interventions|March 10, 2023
Genotype-Guided Selection of Antiplatelet Therapy: The Evidence Moves EastLarisa H Cavallari, Francesco Franchi
Future Cardiology|May 30, 2015
Pharmacogenomics in cardiology--genetics and drug response: 10 years of progressLarisa H Cavallari, Kristin Weitzel
Trends in Cardiovascular Medicine|October 6, 2014
Warfarin pharmacogeneticsJulie A Johnson, Larisa H Cavallari
Pageof 22